Agnati LF, Fuxe K, Zoli M, Ferraguti F, Benfenati F, Ouimet CC, Walaas SI, Hemmings HC, Goldstein M, Greengard P.
1988.
Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum.. Neuroscience. 27(3):785-97.
Pryor KO, Hemmings HC.
2014.
NAP5: intraoperative awareness detected, and undetected.. Br J Anaesth. 113(4):530-3.
Girault JA, Hemmings HC, Williams KR, Nairn AC, Greengard P.
1989.
Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.. J Biol Chem. 264(36):21748-59.
Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai LH, Kwon YT, Girault JA, Czernik AJ et al..
1999.
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons.. Nature. 402(6762):669-71.
Hemmings HC, Nairn AC, Greengard P.
1986.
Protein kinases and phosphoproteins in the nervous system.. Res Publ Assoc Res Nerv Ment Dis. 64:47-69.
Nairn AC, Hemmings HC, Greengard P.
1985.
Protein kinases in the brain.. Annu Rev Biochem. 54:931-76.
McAvoy T, Allen PB, Obaishi H, Nakanishi H, Takai Y, Greengard P, Nairn AC, Hemmings HC.
1999.
Regulation of neurabin I interaction with protein phosphatase 1 by phosphorylation.. Biochemistry. 38(39):12943-9.
Buggy DJ, Hemmings HC.
2014.
Special issue on anaesthesia and cancer.. Br J Anaesth. 113 Suppl 1:i1-3.
Hemmings HC, Jevtovic-Todorovic V.
2013.
Special issue on anaesthetic neurotoxicity and neuroplasticity.. Br J Anaesth. 110 Suppl 1:i1-2.
Hvalby O, Hemmings HC, Paulsen O, Czernik AJ, Nairn AC, Godfraind JM, Jensen V, Raastad M, Storm JF, Andersen P.
1994.
Specificity of protein kinase inhibitor peptides and induction of long-term potentiation.. Proc Natl Acad Sci U S A. 91(11):4761-5.